Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) shares traded down 3.8% during trading on Wednesday. The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares traded hands during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Trading Down 3.8%
The firm has a market capitalization of C$52.28 million and a P/E ratio of -0.37. The stock has a 50-day simple moving average of C$0.26 and a two-hundred day simple moving average of C$0.26. The company has a current ratio of 2.97, a quick ratio of 2.61 and a debt-to-equity ratio of 35.45.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.
See Also
- Five stocks we like better than Emerald Health Therapeutics
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
